BOSTON, MA / ACCESS Newswire / July 31, 2025 / Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. ("Radius" or the "Company"), a specialty biopharmaceutical company focused ...
Orbicular has capabilities in developing dermatology products with a fully-equipped and staff research laboratory in Hyderabad. (Reuters) Alembic Pharmaceuticals Ltd (APL) today said it has entered ...
Tata Capital Healthcare Fund (TCHF) a healthcare-focused private equity fund, has invested approximately $20 million in Orbicular Pharmaceutical Technologies Private Limited for an undisclosed ...
View the original press release on ACCESS Newswire The post Radius Pharmaceuticals Announces Victory in Patent Infringement Case Against Orbicular Pharmaceutical Technologies for Osteoporosis ...
Members of the editorial and news staff of the USA TODAY Network were not involved in the creation of this content. Radius Pharmaceuticals Announces Victory in Patent Infringement Case Against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback